Prediabetes, participation in the English National Health Service Diabetes Prevention Programme, and associations with COVID-19-related mortality: A whole population study
Open Access
- 7 May 2024
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 212, 111692
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Research
- NIHR Imperial Biomedical Research Centre
This publication has 16 references indexed in Scilit:
- Diabetes and the COVID-19 pandemicDiabetologia, 2022
- Metformin is associated with reduced COVID-19 severity in patients with prediabetesDiabetes Research and Clinical Practice, 2022
- Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: An observational studyThe Lancet Regional Health - Europe, 2022
- Prediabetes and COVID-19 severity, an underestimated risk factor: A systematic review and meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Is prediabetes a risk factor for severe COVID‐19?Journal of Diabetes, 2021
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyThe Lancet Diabetes & Endocrinology, 2020
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population studyThe Lancet Diabetes & Endocrinology, 2020
- Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyThe Lancet Diabetes & Endocrinology, 2019
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001